Clinical Trials Browser

Uterine Cervical Neoplasms

Biliary Tract Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Precancerous Conditions, Cholangiocarcinoma

Squamous Cell Carcinoma of Head and Neck

Pathologic Complete Response, Rectal Neoplasms

Hirschsprung Disease, Ganglion Cysts

Breast Neoplasms

Pancreatic Neoplasms

Carcinoma, Renal Cell

Carcinoma, Non-Small-Cell Lung

Neoplasms, Recurrence

Ovarian Neoplasms

Breast Neoplasms

Adenomatous Polyposis Coli

Breast Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Urinary Bladder Neoplasms

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Carcinoma, Renal Cell, Kidney Neoplasms

Breast Neoplasms

Breast Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Breast Neoplasms

Breast Neoplasms

Lung Neoplasms, Tobacco Use Disorder

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Urinary Bladder Neoplasms, Urethral Neoplasms

Breast Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Endometrial Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery

EPIcol

Hepatobiliary Tumors Tissue Samples Acquisition

Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.

IMMUNOREACT2

The Association Between Calretinin and the Function of Ganglion Cells in Hirschsprung Disease

Fibrotic Focus in Breast Cancer

SUCCESS

Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma

Prognostic Value of PD-L1 in NSCLC

SEED

Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective Study

Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)

Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial

Arbre

AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer

Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer

Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer

Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer

Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers

Study of Families With Melanoma

Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy

Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer

Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy